Spots Global Cancer Trial Database for dna vaccine
Every month we try and update this database with for dna vaccine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer | NCT05799144 | Metastatic Orop... Recurrent Oroph... | DNA Vaccine Human Papilloma... Pembrolizumab Computed Tomogr... Magnetic Resona... Magnetic Resona... Biopsy | 18 Years - | Vanderbilt-Ingram Cancer Center | |
DNA Vaccination Against Neuroblastoma | NCT04049864 | Relapsed Neurob... | DNA vaccine Salmonella oral... Lenalidomide | 1 Year - 20 Years | Belarusian Research Center for Pediatric Oncology, Hematology and Immunology | |
Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer | NCT01706458 | Prostate Cancer | sipuleucel-T DNA Vaccine | 18 Years - | University of Wisconsin, Madison | |
Study of gp75 Vaccine in Patients With Stage III and IV Melanoma | NCT00034554 | Malignant Melan... | gp75 DNA vaccin... | 18 Years - | Eli Lilly and Company | |
Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients | NCT01493154 | Head and Neck C... | DNA Vaccine Cyclophosphamid... | 18 Years - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer | NCT01706458 | Prostate Cancer | sipuleucel-T DNA Vaccine | 18 Years - | University of Wisconsin, Madison | |
pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer | NCT05799144 | Metastatic Orop... Recurrent Oroph... | DNA Vaccine Human Papilloma... Pembrolizumab Computed Tomogr... Magnetic Resona... Magnetic Resona... Biopsy | 18 Years - | Vanderbilt-Ingram Cancer Center | |
Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation | NCT00471133 | Melanoma (Skin) Intraocular Mel... | Xenogeneic Tyro... TriGrid Deliver... | 18 Years - | Ichor Medical Systems Incorporated | |
pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer | NCT04090528 | Castration-resi... Metastatic Canc... Prostate Cancer | pTVG-HP pTVG-AR Pembrolizumab | 18 Years - | University of Wisconsin, Madison | |
NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL | NCT06276101 | High-grade Squa... | NWRD08 administ... | 18 Years - 60 Years | Newish Technology (Beijing) Co., Ltd. | |
NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL | NCT06276101 | High-grade Squa... | NWRD08 administ... | 18 Years - 60 Years | Newish Technology (Beijing) Co., Ltd. | |
Safety Study of DNA Vaccine Delivered by Intradermal Electroporation to Treat Colorectal Cancer | NCT01064375 | Colorectal Canc... | tetwtCEA DNA (w... Derma Vax (elec... GM-CSF Cyclophosphamid... | 18 Years - | Karolinska University Hospital | |
Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients | NCT01493154 | Head and Neck C... | DNA Vaccine Cyclophosphamid... | 18 Years - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL | NCT06276101 | High-grade Squa... | NWRD08 administ... | 18 Years - 60 Years | Newish Technology (Beijing) Co., Ltd. | |
pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer | NCT04090528 | Castration-resi... Metastatic Canc... Prostate Cancer | pTVG-HP pTVG-AR Pembrolizumab | 18 Years - | University of Wisconsin, Madison | |
Safety Study of DNA Vaccine Delivered by Intradermal Electroporation to Treat Colorectal Cancer | NCT01064375 | Colorectal Canc... | tetwtCEA DNA (w... Derma Vax (elec... GM-CSF Cyclophosphamid... | 18 Years - | Karolinska University Hospital | |
Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation | NCT00471133 | Melanoma (Skin) Intraocular Mel... | Xenogeneic Tyro... TriGrid Deliver... | 18 Years - | Ichor Medical Systems Incorporated |